Medtronic, announced the signing of a formal agreement to purchase Affera, Inc., a privately held medical technology business situated in the Boston region. For the treatment of patients with cardiac arrhythmias (irregular heartbeats) such atrial fibrillation, Affera develops and produces catheter-based cardiac ablation technologies, such as a unique localized pulsed field ablation solution (AF).
Biosense Webster, Inc., a subsidiary of Johnson & Johnson MedTech, announced the availability of the OCTARAY Mapping Catheter with TRUEref Technology, which is driven by the CARTO 3 Version 7 System. Atrial fibrillation and other cardiac arrhythmias were produced using the OCTARAY Mapping Catheter (AFib).
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?